Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. AS Latvijas Juras medicinas centrs's shares outstanding for the quarter that ended in Dec. 2025 was 0.80 Mil.
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Shares Outstanding (EOP) Explanation
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
AS Latvijas Juras medicinas centrs Shares Outstanding (EOP) Related Terms
AS Latvijas Juras medicinas centrs Shares Outstanding (EOP) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AS Latvijas Juras medicinas centrs Shares Outstanding (EOP) Chart
ORSE:LJM1R vs HCA, THC, ENSG: Shares Outstanding (EOP) Comparison
For the Medical Care Facilities subindustry, AS Latvijas Juras medicinas centrs's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AS Latvijas Juras medicinas centrs Shares Outstanding (EOP) vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AS Latvijas Juras medicinas centrs's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where AS Latvijas Juras medicinas centrs's Shares Outstanding (EOP) falls into.
AS Latvijas Juras medicinas centrs Shares Outstanding (EOP) Calculation
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
What does a Shares Outstanding (EOP) of 0.80 Mil mean?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a Shares Outstanding (EOP) of 0.80 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on AS Latvijas Juras medicinas centrs and its competitors.
Is AS Latvijas Juras medicinas centrs' Shares Outstanding (EOP) too high?
AS Latvijas Juras medicinas centrs' current Shares Outstanding (EOP) is 0.80 Mil. Overall, AS Latvijas Juras medicinas centrs has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does AS Latvijas Juras medicinas centrs' Shares Outstanding (EOP) compare to HCA and THC?
AS Latvijas Juras medicinas centrs' Shares Outstanding (EOP) of 0.80 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on AS Latvijas Juras medicinas centrs and its competitors. AS Latvijas Juras medicinas centrs's current Shares Outstanding (EOP) is 0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AS Latvijas Juras medicinas centrs stock overvalued right now?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a current Shares Outstanding (EOP) of 0.80 Mil. The stock's GF Value™ is €7.78, compared to a current price of €7.80 — trading 0.3% above its estimated fair value. The current Shares Outstanding (EOP) is 0.80 Mil. AS Latvijas Juras medicinas centrs' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For AS Latvijas Juras medicinas centrs (ORSE:LJM1R), the current Shares Outstanding (EOP) is 0.80 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Overvalued in 2026?
Based on GuruFocus' analysis, AS Latvijas Juras medicinas centrs stock appears to be overvalued.
The current stock price of €7.80 is trading 0.3% above its estimated GF Value™ of €7.78.
Key valuation signals for ORSE:LJM1R:
Shares Outstanding (EOP): 0.80 Mil
GF Value™: €7.78 vs. price of €7.80 (0.3% above fair value)
No single metric tells the full story. See the ORSE:LJM1R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AS Latvijas Juras medicinas centrs Business Description
AS Latvijas Juras medicinas centrs is a private certified medical institution in Latvia providing outpatient and inpatient healthcare services through qualified staff and modern equipment. Its core activities include hospital services, orthopaedic retail, medical and dental practice, human health and residential care, social work activities, and physical well-being services. It operates the Women's Health Clinic, offering gynecological consultations, pregnancy care, diagnostics, postpartum services, gynecological care for girls, and surgery. The centre also provides vaccination, rehabilitation, a Multiple Sclerosis Center, medical commission, home visits, laboratory services, physical medicine and massage, therapeutic procedures, medical treatment, and anesthesia and intensive care.
59GF Score
Get the complete analysis for ORSE:LJM1R
Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORSE:LJM1R has been successfully added to your 
